The Next Wave of Immunotherapy and Cancer Treatments

Explore the cutting-edge advancements in immunotherapy and cancer treatments in this panel discussion from the Milken Institute Global Conference 2024. Delve into the revolutionary approach of harnessing the body's immune system to combat various refractory cancers, including melanoma, lymphoma, lung, and liver cancers. Learn about the groundbreaking discoveries that led to the 2018 Nobel Prize in Physiology or Medicine, awarded to Drs. James Allison and Tasuku Honjo for their work on inhibition of negative immune regulation. Gain insights into the effectiveness of immunotherapies across multiple cancer types and their potential antiviral applications. Join expert panelists as they discuss future developments in immunotherapy, including mRNA vaccines, cell-based approaches like TIL cell and CAR-T therapy, and their implications for patients, investors, the life-sciences industry, and the overall landscape of cancer treatments. Hear from industry leaders, including representatives from the Melanoma Research Alliance, Prostate Cancer Foundation, Iovance Biotherapeutics, Stanford University School of Medicine, Immunocore, and AstraZeneca, as they share their expertise and vision for the next wave of cancer therapies.

The Next Wave of Immunotherapy and Cancer Treatments | Milken Institute Global Conference 2024